DPT Meeting: Panel 1 – Protocol Objectives & Eligibility PANEL Discussion 1: Protocol Objectives and Eligibility Moderators: Abby Bronson, Scott Berry Panelists: Joanne Donovan, MD, PhD, Catabasis Pharmaceuticals Michael Panzara, MD, MPH, Wave Life Sciences Hank Mayer, MD, Children’s Hospital of Philadelphia Paula Clemens, MD, University of Pittsburgh Gretchen Egner, Parent/Advocate 6 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings You may also like 7:48 What is a Post Market Study? 6 years ago Approved Therapies,Conferences & Meetings 35:48 DPT Meeting: Welcome & Introduction 6 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 38:43 DPT Meeting: FDA Opening Remarks 6 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 23:02 DPT Meeting: DPT Protocol in Practice 6 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 43:44 DPT Meeting: Overview of DPT Proposed Protocol 6 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:07:15 DPT Meeting: Panel 2 – Endpoints & Schedule of Events 6 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 44:50 DPT Meeting: Panel 3 – Operations & Governance 6 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:02:36 DPT Meeting: Parent Commentary & Advocacy Perspective 6 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings «1…232425262728»Page 25 of 28